163 related articles for article (PubMed ID: 17969549)
21. The role of health insurance coverage in cancer screening utilization.
Robinson JM; Shavers V
J Health Care Poor Underserved; 2008 Aug; 19(3):842-56. PubMed ID: 18677074
[TBL] [Abstract][Full Text] [Related]
22. A prostate cancer screening trial in Canada?
Miller A
Can J Oncol; 1994 Nov; 4 Suppl 1():110-2; discussion 113-8. PubMed ID: 8853502
[No Abstract] [Full Text] [Related]
23. Life expectancy and the value of early detection.
Howard DH
J Health Econ; 2005 Sep; 24(5):891-906. PubMed ID: 16129128
[TBL] [Abstract][Full Text] [Related]
24. Review of the evidence for a colorectal cancer screening programme in elderly people.
Quarini C; Gosney M
Age Ageing; 2009 Sep; 38(5):503-8. PubMed ID: 19581336
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
[TBL] [Abstract][Full Text] [Related]
26. Cancer screening - pros, cons, choice, and the patient.
Trevena L
Aust Fam Physician; 2009 Apr; 38(4):188-92. PubMed ID: 19350066
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology and treatment of extramammary Paget disease in the Netherlands.
Siesling S; Elferink MA; van Dijck JA; Pierie JP; Blokx WA
Eur J Surg Oncol; 2007 Oct; 33(8):951-5. PubMed ID: 17215101
[TBL] [Abstract][Full Text] [Related]
28. Healthy aging: guidelines for cancer screening and immunizations.
Noe CA; Barry PP
Geriatrics; 1996 Jan; 51(1):75-7, 81-3. PubMed ID: 8543201
[TBL] [Abstract][Full Text] [Related]
29. Clarification of prostate cancer screening recommendations.
Merenstein D
Am Fam Physician; 2004 Sep; 70(5):817; discussion 817, 821. PubMed ID: 15368718
[No Abstract] [Full Text] [Related]
30. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
31. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
32. Colonoscopy is the preferred colorectal cancer screening method in a population-based program.
Marbet UA; Bauerfeind P; Brunner J; Dorta G; Valloton JJ; Delcò F
Endoscopy; 2008 Aug; 40(8):650-5. PubMed ID: 18609465
[TBL] [Abstract][Full Text] [Related]
33. Recommendation for and receipt of cancer screenings among medicaid recipients 50 years and older.
DuBard CA; Schmid D; Yow A; Rogers AB; Lawrence WW
Arch Intern Med; 2008 Oct; 168(18):2014-21. PubMed ID: 18852404
[TBL] [Abstract][Full Text] [Related]
34. Costs in primary care of investigating symptoms suspicious of cancer in a defined population.
Månsson J; Marklund B; Carlsson P
Scand J Prim Health Care; 2006 Dec; 24(4):243-50. PubMed ID: 17118865
[TBL] [Abstract][Full Text] [Related]
35. Economic evaluation of prostate cancer screening with prostate-specific antigen.
Imamura T; Yasunaga H
Int J Urol; 2008 Apr; 15(4):285-8. PubMed ID: 18380812
[TBL] [Abstract][Full Text] [Related]
36. Task force weighs in on prostate cancer screening.
CA Cancer J Clin; 2008; 58(6):320-1. PubMed ID: 18941123
[No Abstract] [Full Text] [Related]
37. [Arguments against implementing a population-based screening programme for colorectal cancer].
Bonneux L
Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
[TBL] [Abstract][Full Text] [Related]
38. Influence of Age, Health, and Function on Cancer Screening in Older Adults with Limited Life Expectancy.
Schoenborn NL; Huang J; Sheehan OC; Wolff JL; Roth DL; Boyd CM
J Gen Intern Med; 2019 Jan; 34(1):110-117. PubMed ID: 30402822
[TBL] [Abstract][Full Text] [Related]
39. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
Inadomi JM
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
[TBL] [Abstract][Full Text] [Related]
40. The importance of relationships in the experience of cancer: a re-working of the policy ideal of the whole-systems approach.
Illingworth N; Forbat L; Hubbard G; Kearney N
Eur J Oncol Nurs; 2010 Feb; 14(1):23-8. PubMed ID: 19748315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
